Table 1.
Patients’ characteristics n (%)
| BAL (n=258) | TIVA (n=36) | INH (n=104) | |
|---|---|---|---|
| Sex | |||
| Male | 174 (67.44) | 23 (63.89) | 73 (70.19) |
| Female | 84 (32.56) | 13 (36.11) | 31 (29.81) |
| Pathology | |||
| Adenocarcinoma | 209 (81.01) | 26 (72.22) | 0 (-) |
| Adenosquamous carcinoma | 3 (1.16) | 0 (-) | 86 (82.69) |
| Interstitialoma | 5 (1.94) | 1 (2.78) | 2 (1.92) |
| Lymphadenoma | 8 (3.10) | 0 (-) | 0 (-) |
| Undifferentiated carcinoma | 9 (3.49) | 1 (2.78) | 7 (6.73) |
| Squamous carcinoma | 1 (0.39) | 0 (-) | 7 (6.73) |
| Signet ring cell cancer | 22 (8.53) | 8 (22.22) | 0 (-) |
| Poorly differentiated neuroendocrine carcinoma | 1 (0.39) | 0 (-) | 0 (-) |
| Underlying diseases | |||
| Yes | 161 (62.40) | 24 (66.67) | 64 (61.54) |
| No | 97 (37.60) | 12 (33.33) | 40 (38.46) |
| ASA | |||
| I | 84 (32.56) | 11 (30.56) | 21 (20.19) |
| II | 174 (67.44) | 25 (69.44) | 83 (79.81) |
| Age (years) | 59.67±12.21 | 58.42±12.04 | 58.76±9.95 |
| <65 | 166 (64.34) | 14 (38.89) | 24 (23.08) |
| ≥65 | 92 (35.66) | 22 (61.11) | 80 (76.92) |
| Weight (kg) | 61±10.41 | 60.24±11.86 | 63.15±10.78 |
| Medical insurance | |||
| Yes | 150 (58.14) | 21 (58.33) | 63 (60.58) |
| No | 108 (41.86) | 15 (41.67) | 41 (39.42) |
| Postoperative analgesia | |||
| Yes | 233 (90.31) | 30 (83.33) | 96 (92.31) |
| No | 25 (9.69) | 6 (16.67) | 8 (7.69) |
BAL, balanced anesthesia; TIVA, total intravenous anesthesia; INH, inhalational anesthesia; ASA, American Society of Anesthesiologists.